P705 Switching from originator to biosimilar infliximab—real-world data from 18 months prospective follow-up of a single-centre IBD population

Subjects

Subjects :

education.field_of_study
Pediatrics
medicine.medical_specialty
business.industry
Population
Gastroenterology
Biosimilar
General Medicine
Infliximab
03 medical and health sciences
Single centre
0302 clinical medicine
030220 oncology & carcinogenesis
medicine
030211 gastroenterology & hepatology
education
business
Real world data
Infliximab-dyyb
medicine.drug

Details

ISSN :

18764479 and 18739946

Volume :

12

Database :

OpenAIRE

Journal :

Journal of Crohn's and Colitis

Accession number :

edsair.doi...........8275a136a524200a58a0dfde020a5ae7